Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
LB PharmaceuticalsLBRX | Open-market buy | 25/09/12 | 25/09/16 | 333,333 sh2 trades | $15.00avg. | $4,999,995 | No record | |
LB PharmaceuticalsLBRX | Open-market buy | 25/09/12 | 25/09/16 | 2,666,666 sh2 trades | $15.00avg. | $39,999,990 | No record | |
Ran NussbaumDirector | LB PharmaceuticalsLBRX | Open-market buy | 25/09/12 | 25/09/16 | 1,000,000 sh | $15.00 | $15,000,000 | +242.9% |
Pontifax Management 4 G.P.10% Owner | LB PharmaceuticalsLBRX | Open-market buy | 25/09/12 | 25/09/16 | 1,000,000 sh | $15.00 | $15,000,000 | +242.9% |